共 7 条
[1]
发掘慢性阻塞性肺疾病临床终点预测性替代指标纵向研究成果及意义[J] 谭博;杜永成;张爱珍;李毅; 中国实用内科杂志 2016, 08
[2]
[3]
慢性阻塞性肺疾病的肺功能检查中FEV_1与IC的临床应用[J] 郑劲平; 中国实用内科杂志 2014, S1
[4]
Effectiveness of bevacizumab exposure beyond disease progression in patients with non–small‐cell lung cancer: analyses of the ARIES observational cohort study[J] Larry Leon;Michael Kosty;Mohammad Jahanzeb;David Spigel;Antoinette J. Wozniak;Julie Brahmer;Susan Fish;E. Dawn Flick;Sebastien J. Hazard;Thomas J. Lynch Pharmacoepidemiology and Drug Safety 2016,
[5]
Blood eosinophil counts; exacerbations; and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials[J] Steven Pascoe;Nicholas Locantore;Mark T Dransfield;Neil C Barnes;Ian D Pavord The Lancet Respiratory Medicine 2015,
[6]
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study[J] MeiLan K Han;Hana Muellerova;Douglas Curran-Everett;Mark T Dransfield;George R Washko;Elizabeth A Regan;Russell P Bowler;Terri H Beaty;John E Hokanson;David A Lynch;Paul W Jones;Antonio Anzueto;Fernando J Martinez;James D Crapo;Edwin K Silverman;Barry J Make The Lancet Respiratory Medicine 2012,
[7]
Randomized; double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis[J] R.G. Masterton;C.J. Burley International Journal of Antimicrobial Agents 2001,